Lakefront Biotherapeutics American Depositary Shares
Market Cap
1.8B
Short interest (May 15)
2.4%
Net Short (Jun 03 ): 0.0%
Borrow Fee
1.11%
↓ 2.3%
Available Shares
1M
↓ 7.1%
Price Chart
Company Overview
Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.